Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Rising Leaders 2025: Abbas Kazimi’s Vision For Nimbus Therapeutics

Jul 16 2025

• By David Wild

small green plant sprouting out of crack in concrete. — Resilience and a sense of grounding are key to Abbas Kazimi's leadership philosophy (Shutterstock)

Related Content

Failing Fast: New And Strategic Ways To Prune Your Portfolio

Dec 11 2024

Potential Competitor To BMS’s Sotyktu Bites The Dust

Jul 30 2024

Takeda Will Take TYK2 Inhibitor Into Phase III, Looks For Dosing Edge Over BMS Rival

Nov 08 2023

Takeda Aims At BMS’s Sotyktu In $4bn Deal For Nimbus’s TYK2 Inhibitor

Dec 13 2022

Nimbus Nips At BMS’s Heels With Psoriasis Results For TYK2 Inhibitor

Nov 30 2022

Related Companies

Nimbus Therapeutics, Inc.

Takeda Pharmaceutical Co. Ltd.

Eli Lilly and Company

Gilead Sciences, Inc.

Galapagos NV

Additional Topics

Rising Leaders Leadership Business Strategies Growth Deals Innovation

More from Rising Leaders

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window